🇺🇸 FDA
Patent

US 7335744

Prostate cancer specific internalizing human antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 7335744 (Prostate cancer specific internalizing human antibodies) held by The Regents of the California University expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the California University
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61P, A61P35/00